Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled study of the investigational drug
uridine as a treatment for suicidal ideation in veterans.
The investigators hypothesize that the administration of a naturally occurring dietary
supplement, uridine, will rapidly reduce suicidal ideation in veterans. The purpose of this
study is to determine whether 4 weeks of uridine supplementation is an effective treatment
for suicidal ideation in veterans, when compared to a group taking a placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Perry Renshaw VA Office of Research and Development